These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 30926552
1. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature. Yonezawa N, Murakami H, Demura S, Kato S, Yoshioka K, Takeuchi A, Shinmura K, Yokogawa N, Shimizu T, Oku N, Kitagawa R, Handa M, Tsuchiya H. World Neurosurg; 2019 Jul; 127():38-46. PubMed ID: 30926552 [Abstract] [Full Text] [Related]
2. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H. Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950 [Abstract] [Full Text] [Related]
3. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report. Kinoshita H, Orita S, Yonemoto T, Ishii T, Iwata S, Kamoda H, Tsukanishi T, Inage K, Abe K, Inoue M, Norimoto M, Umimura T, Fujimoto K, Shiga Y, Kanamoto H, Furuya T, Takahashi K, Ohtori S. J Med Case Rep; 2019 Apr 26; 13(1):116. PubMed ID: 31023361 [Abstract] [Full Text] [Related]
4. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report. Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW. JBJS Case Connect; 2016 Apr 26; 6(3):e74. PubMed ID: 29252651 [Abstract] [Full Text] [Related]
5. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature. Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE. Spine J; 2024 Jun 26; 24(6):1056-1064. PubMed ID: 38301904 [Abstract] [Full Text] [Related]
6. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases. Dubory A, Missenard G, Domont J, Court C. Spine (Phila Pa 1976); 2016 Jun 26; 41(11):E654-E660. PubMed ID: 27244112 [Abstract] [Full Text] [Related]
7. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP. Eur J Cancer; 2017 May 26; 76():118-124. PubMed ID: 28324746 [Abstract] [Full Text] [Related]
8. Primary thoracic giant cell tumor of bone sensitive to steroids. Yang H, Im GH, Nielsen GP, Kheterpal A, Schwab JH. Skeletal Radiol; 2018 Oct 26; 47(10):1431-1435. PubMed ID: 29502130 [Abstract] [Full Text] [Related]
9. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum. Bukata SV, Blay JY, Rutkowski P, Skubitz K, Henshaw R, Seeger L, Dai T, Jandial D, Chawla S. Spine (Phila Pa 1976); 2021 Mar 01; 46(5):277-284. PubMed ID: 33038190 [Abstract] [Full Text] [Related]
11. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report. Tang Q, Lu J, Zhu X, Song G, Wu H, Xu H, Wang A, Wang J. Eur Spine J; 2023 Dec 01; 32(12):4297-4305. PubMed ID: 37318598 [Abstract] [Full Text] [Related]
12. Can Denosumab cure giant cell tumors of the spine? A case report and literature review. Xará-Leite F, Coutinho L, Fleming C, Magalhães M, Oliveira V, Rodrigues-Pinto R, Cardoso P. Eur J Orthop Surg Traumatol; 2020 Jan 01; 30(1):19-23. PubMed ID: 31529151 [Abstract] [Full Text] [Related]
13. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May 01; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
14. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab. Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E. Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393 [Abstract] [Full Text] [Related]
15. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation. Kerr DA, Brcic I, Diaz-Perez JA, Shih A, Wilky BA, Pretell-Mazzini J, Subhawong TK, Nielsen GP, Rosenberg AE. Am J Surg Pathol; 2021 Jan 01; 45(1):93-100. PubMed ID: 32773532 [Abstract] [Full Text] [Related]
16. Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine: A Case Report. Law GW, Yeo NEM, Howe TS, Tan YZ, Tan SB, Siddiqui MMA. Spine (Phila Pa 1976); 2018 May 01; 43(9):E551-E556. PubMed ID: 29016442 [Abstract] [Full Text] [Related]
17. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]
18. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab. Palmerini E, Seeger LL, Gambarotti M, Righi A, Reichardt P, Bukata S, Blay JY, Dai T, Jandial D, Picci P. BMC Cancer; 2021 Jan 22; 21(1):89. PubMed ID: 33482769 [Abstract] [Full Text] [Related]
19. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images. Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS. J Orthop Sci; 2018 May 22; 23(3):570-577. PubMed ID: 29429890 [Abstract] [Full Text] [Related]
20. Combining two-stage surgery and denosumab treatment in a patient with giant cell tumour of the lumbar spine with intraperitoneal growth. Liu S, Zhou X, Song A, Huo Z, Wang Y, Liu Y. Postgrad Med J; 2019 Feb 22; 95(1120):106-107. PubMed ID: 30425137 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]